Hawkins Richard J

CIK 00013076324 companiesAUSTIN, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001307632

Recent Transactions

50 trades

Award
Savara Inc$SVRA
Common Stock
2025-12-09+40,000→ 161,326 total
Sale
Savara Inc$SVRA
Common Stock
2024-12-16$3.32/sh−8,000→ 67,241 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−35,400→ 0 total
Award
Savara Inc$SVRA
Common Stock
2024-12-12+40,000→ 75,241 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−35,400→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−28,475→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Common Stock
2024-12-12−753,093→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Common Stock
2024-12-12−4,469→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−135,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−19,624→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−35,400→ 0 total
Purchase
PLUS THERAPEUTICS, INC.$PSTV
Common Stock
2024-09-13$1.50/sh+4,000→ 15,188 total
Purchase
PLUS THERAPEUTICS, INC.$PSTV
Common Stock
2024-09-12$1.35/sh+6,285→ 11,188 total
Award
PLUS THERAPEUTICS, INC.$PSTV
Stock Option (Right to Buy)
2024-09-11+3,650→ 3,650 total
Award
PLUS THERAPEUTICS, INC.$PSTV
Warrants (Right to buy)
2024-05-08+9,804→ 9,804 total
Purchase
PLUS THERAPEUTICS, INC.$PSTV
Common Stock
2024-05-08$2.04/sh+4,902→ 4,903 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-04-01+35,400→ 35,400 total
Award
LUMOS PHARMA, INC.
Common Stock
2024-04-01$2.84/sh+4,500→ 754,615 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2024-04-01$2.84/sh−1,522→ 753,093 total
Award
PLUS THERAPEUTICS, INC.$PSTV
Stock Option (Right to Buy)
2024-02-22+2,250→ 2,250 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2024-02-01$3.01/sh−690→ 750,115 total
Award
Savara Inc$SVRA
Common Stock
2023-12-14+22,500→ 35,241 total
Exercise/Conversion
Savara Inc$SVRA
Common Stock
2023-12-11$0.82/sh+10,841→ 12,741 total
Exercise/Conversion
Savara Inc$SVRA
Stock Option (Right to Buy)
2023-12-11−10,841→ 0 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2023-04-01$3.31/sh−1,522→ 750,805 total
Purchase
PLUS THERAPEUTICS, INC.$PSTV
Series F Preferred Stock
2023-03-03$1000.00/sh+1→ 1 total
Award
PLUS THERAPEUTICS, INC.$PSTV
Stock Option (Right to Buy)
2023-02-15+20,182→ 20,182 total
Award
LUMOS PHARMA, INC.
Common Stock
2023-02-01$3.52/sh+4,500→ 752,743 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2023-02-01$3.52/sh−416→ 752,327 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2023-02-01+35,400→ 35,400 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2022-12-13+40,000→ 40,000 total
Exercise/Conversion
Savara Inc$SVRA
Stock Option (Right to Buy)
2022-12-07−1,172→ 0 total
Exercise/Conversion
Savara Inc$SVRA
Common Stock
2022-12-07$0.65/sh+1,172→ 1,900 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2022-09-23$8.80/sh+208→ 4,469 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2022-09-21$8.84/sh+2,214→ 4,261 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2022-09-20$8.75/sh+1,506→ 2,047 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2022-09-19$8.65/sh+541→ 541 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2022-04-01$9.23/sh−1,466→ 748,243 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2022-02-01$10.02/sh−173→ 749,709 total
Award
LUMOS PHARMA, INC.
Common Stock
2022-02-01$10.02/sh+4,500→ 749,882 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2022-02-01+35,400→ 35,400 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2021-12-14+40,000→ 40,000 total
Exercise/Conversion
Savara Inc$SVRA
Common Stock
2021-12-13$0.55/sh+728→ 728 total
Exercise/Conversion
Savara Inc$SVRA
Stock Option (Right to Buy)
2021-12-13−728→ 0 total
Award
PLUS THERAPEUTICS, INC.$PSTV
Stock Option (Right to Buy)
2021-06-11+6,336→ 6,336 total
Award
PLUS THERAPEUTICS, INC.$PSTV
Stock Option (Right to Buy)
2021-06-11+40,000→ 40,000 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2021-04-01$12.25/sh−1,522→ 745,382 total
Award
LUMOS PHARMA, INC.
Common Stock
2021-02-01+2,329→ 746,904 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2021-02-01+28,475→ 28,475 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2020-12-16+40,000→ 40,000 total

Companies

Recent Filings

Address

900 S. CAPITAL OF TEXAS HIGHWAY, SUITE 150

AUSTIN, TX, 78746

View on SEC.gov